Derivation and Validation of a Necroptosis-Related lncRNA Signature in Patients with Ovarian Cancer

Figure 6

Construction and evaluation of the signature-based prognostic nomogram predicting OS. (a) The prognostic nomogram for the prediction of 1-, 3- and 5-year OS in ovarian cancer. The calibration plots of the testing cohort (b) and test cohort (c). The ROC of the nomogram for predicting 1-, 3-, and 5-year OS in the testing cohort (d) and test cohort (e). OS, overall survival.

(a)

(b)

(c)

(d)

(e)